ArticleAnnals of medicine and surgery (2012)2026

Forimtamig: a potent GPRC5D-targeted bispecific antibody in multiple myeloma.

Hafsa Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.